Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin a

Abstract

These 12-month results suggest that low-dose CsA decreases the rate of further joint damage in previously involved joints as well as the rate of new joint involvement in previously uninvolved joints, in patients with early RA.